Click here to watch Dr. Virginia Devonshire discuss the case and the responses to the survey.
Thomas, 38, is a chemical engineer who initially presented in 2019 with optic neuritis followed two months later by a myelopathic episode. MRI was highly active with two gadolinium-enhancing T1 and multiple T2 lesions. EDSS was 2.5 (optic 1, sensory 2, bladder 2). Thomas had no relevant medical conditions other than obesity; his body weight was 120 kg (BMI 34 kg/m2) at presentation. Read More
SPECIAL REPORT
Long-term treatment with ofatumumab, a fully human anti-CD20 monoclonal antibody, is associated with a favourable safety profile and sustained efficacy, according to a newly-published analysis of the ALITHIOS long-term extension (Hauser et al. Mult Scler 2023; epublished September 11, 2023). The study is the most recent to support the earlier use of high-efficacy therapy in patients with multiple sclerosis. Read More
This year’s joint ECTRIMS-ACTRIMS congress was held on October 11-13 in Milan, Italy. Click here for the Daily Highlights. Read More
Help make the NeuroSens coverage of MSMilan 2023 (The 9th Joint ECTRIMS-ACTRIMS Meeting) relevant to you.
Complete the survey below to tell us what topics are of greatest interest to you. Read More